Atomi Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.14M Sell
9,937
-292
-3% -$296K 0.28% 71
2025
Q4
$11M Buy
10,229
+1,514
+17% +$1.45M 0.32% 54
2025
Q3
$6.65M Buy
8,715
+564
+7% +$420K 0.22% 86
2025
Q2
$6.35M Buy
8,151
+8
+0.1% +$6.22K 0.24% 80
2025
Q1
$6.72M Buy
8,143
+1,904
+31% +$1.58M 0.31% 65
2024
Q4
$4.82M Buy
6,239
+845
+16% +$700K 0.24% 81
2024
Q3
$4.78M Buy
5,394
+111
+2% +$99.8K 0.3% 68
2024
Q2
$4.78M Buy
5,283
+550
+12% +$440K 0.35% 58
2024
Q1
$3.68M Buy
4,733
+1,046
+28% +$744K 0.34% 65
2023
Q4
$2.15M Buy
3,687
+1,628
+79% +$950K 0.3% 68
2023
Q3
$1.11M Sell
2,059
-48
-2% -$24.7K 0.37% 73
2023
Q2
$988K Buy
2,107
+249
+13% +$104K 0.45% 57
2023
Q1
$638K Buy
+1,858
New +$627K 0.36% 80

Other funds holding LLY

Atomi Financial Group's LLY Position: Q1 2026 in Review

Atomi Financial Group reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2026, selling an estimated $296K and leaving 9,937 shares worth $9.14M. The position accounts for 0.28% of the portfolio, ranked #71.

Atomi Financial Group first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $11M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Atomi Financial Group held 9,937 shares of Eli Lilly worth $9.14M as of Q1 2026.
  • Atomi Financial Group sold 292 Eli Lilly shares in Q1 2026, an estimated $296K.
  • Eli Lilly made up 0.28% of Atomi Financial Group's portfolio in Q1 2026, its #71 holding.
  • Atomi Financial Group first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • Atomi Financial Group's Eli Lilly position peaked at $11M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.